Cytarabine Injection, Solution
Product Images NDC 61703-155
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cytarabine Structural Formula (Cytarabine 02)
Hospira Logo (Cytarabine 03)
Principal Display Panel (20 mL Glass Vial Label)
This text appears to be a pharmaceutical label detailing information about an injectable medication. It states that the medication is a cytotoxic agent and is intended for intravenous, intrathecal, and subcutaneous use only. The label also specifies that it is a single-dose vial with a concentration of 100 mg/mL.*
Principal Display Panel (20 mL Glass Vial Carton)
This is a description of a Cytarabine injection, a cytotoxic agent used for intravenous, intrathecal, and subcutaneous administration. The solution is preservative-free and should be discarded if unused. Each mL contains 100 mg Cytarabine and Water for Injection. The pH is adjusted to 7.7 using sodium hydroxide and/or hydrochloric acid. It is essential to protect it from light, store between 20°C to 25°C, and retain it in the carton until use. The product information and dosage instructions can be found in the package insert. The injection is a single-dose vial distributed by Hospira, Inc. The 2D DataMatrix code is used for serialization and includes batch information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.